Please sign in to follow a disease.
New nerve block may ease pain after bypass surgery
NCT ID NCT06908681
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a nerve block given before heart surgery can reduce pain and the need for opioids afterward. 76 patients received either the block or a placebo injection. Researchers measured pain scores and opioid use in the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If it works, this nerve block could become a standard way to manage pain after heart surgery, reducing the need for strong painkillers.
- What could go wrong
- This is a small, completed trial. The results may not apply to all heart surgery patients, and the block may not provide meaningful pain relief compared to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
76 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Elective coronary artery bypass grafting (CABG) via median sternotomy planned * Able to provide written informed consent * Able to communicate symptoms reliably with the research team Exclusion Criteria: * Emergency CABG surgery * Infection or open wound at the injection site * Coagulopathy * Hepatic or renal failure * Reoperation cases * Incomplete or missing data
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery bypass grafting (CABG) surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Health Sciences, Konya City Hospital
Konya, 42080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heart stent patients go home in 6 hours?
- Two nerve blocks go head to head for chest surgery pain
- Can a Nurse's confidence ease a Patient's postoperative pain?
- Antidepressant may double as pain reliever after gallbladder surgery
- Nerve blocks put to the test for breast surgery pain
- A Non-Opioid pain drug takes aim at Surgery's opioid problem